A randomized study of solriamfetol for excessive sleepiness in narcolepsy
Michael J. Thorpy(Montefiore Medical Center), Yves Dauvilliers(Inserm), Bruce Corser(Sleep Management Institute), Hélène A. Emsellem(California Center for Sleep Disorders), Giuseppe Plazzi(Istituto delle Scienze Neurologiche di Bologna), Geert Mayer, Dan Chen(Yunnan University), Yuan Lü(Jazz Pharmaceuticals (United States)), Colin M. Shapiro(University of Toronto), Jed Black(Jazz Pharmaceuticals (United States)), Hao Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Lawrence P. Carter(Jazz Pharmaceuticals (United States))
Cited by 324
Related Papers
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
National Sleep Foundation's sleep quality recommendations: first report
|Sleep Health|2016|1.3k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Narcolepsy with cataplexy
|The Lancet|2007|716
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
|Nature Reviews Neurology|2019|634